Cell Line Development Market by Application, Type, Source & Product - 2019

MarketsandMarkets Presents

Cell Line Development Market worth $3.96 Billion by 2019

http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html

The “Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019” analyzes and studies the major market drivers, threats, opportunities, and challenges.

Browse 114 Market Data Tables 64 Figures 225 Pages and in-depth TOC on “Cell Line Development Market” http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html Early buyers will receive 10% customization on reports.

http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html

The cell line development market is highly competitive with a large number of players, including both big and small players, operating in this market. Cell lines are used in many pharmaceutical and biotechnology industries, academic research institutes, and diagnostic laboratories. In order to develop high-yielding and stable cell lines, companies and research institutes are engaged in research activities to develop more efficient technologies for development of cell lines.

The global market is segmented on the basis of product, source, type, application, and geography. The global market, by product is categorized into equipment and media and reagents. The media and reagents segment is further divided into serum, media, and reagents. The reagents market is expected to account for the largest share of the market.

However, media is expected to be the fastest-growing segment in the reagents market.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=152900899

http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html

The cell line development market, by type is divided into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines accounted for the largest share of the market, by type. However, the primary cell lines segment is expected to grow at the fastest rate in the market, by type.

Based on the source of cell lines, the market is segmented into mammalians, insects, and amphibians. The mammalian segment is the largest and the fastest growing segment of the market, by source.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=152900899

On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. In 2014, the bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and manufacturing of recombinant protein therapeutics. http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html

The key factors that are expected to spur this market are increased demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies. However, developing stable and authentic cell lines poses a major challenge for this market. Some of the opportunities for cell line development market are low income countries and increasing risk of pandemics and communicable diseases.

The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW).

Interested In Purchasing: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=152900899 Some of the major players in the global market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany). http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html

About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market152900899.html

Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets